🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

18,54 USD

Máx. histórico

178,74

2142 días

Split 1:6 del 12/07/2012

Caída desde máximo

-89,63%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,20%

Cierre anterior

18,32

Rango de hoy

18,29 – 18,81

Volumen hoy

1.397.929

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,44%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 22 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
10/10/2022 110,25 110,55 107,62 108,70 -2,37% 2,66% 747.000
07/10/2022 114,30 114,54 111,17 111,34 -3,03% 2,95% 1.245.600
06/10/2022 111,61 118,44 111,05 114,82 +3,80% 6,62% 1.392.500
05/10/2022 111,36 112,24 109,68 110,62 -0,76% 2,30% 565.700
04/10/2022 111,33 112,09 107,03 111,47 +1,39% 4,55% 957.100
03/10/2022 110,47 112,30 108,65 109,94 -0,54% 3,30% 636.200
30/09/2022 109,26 113,67 108,82 110,54 +0,83% 4,44% 1.034.800
29/09/2022 109,94 111,60 108,28 109,63 -0,25% 3,02% 896.600
28/09/2022 110,11 111,00 108,93 109,91 +1,46% 1,88% 749.700
27/09/2022 108,14 109,94 107,21 108,33 +2,05% 2,52% 658.800
26/09/2022 108,07 110,38 106,01 106,15 -1,89% 4,04% 581.400
23/09/2022 109,57 109,70 104,68 108,19 -2,42% 4,58% 846.300
22/09/2022 109,97 111,45 107,33 110,87 +0,66% 3,75% 677.500
21/09/2022 114,11 115,40 110,07 110,14 -3,30% 4,67% 1.024.500
20/09/2022 115,25 116,25 112,97 113,90 -1,17% 2,85% 986.900
19/09/2022 111,52 115,78 110,94 115,25 +2,91% 4,34% 1.349.800
16/09/2022 109,83 112,39 108,17 111,99 +1,18% 3,84% 1.836.400
15/09/2022 108,40 112,11 106,66 110,68 +2,89% 5,03% 1.663.200
14/09/2022 104,57 107,67 103,05 107,57 +2,29% 4,42% 4.615.600
13/09/2022 110,67 112,71 104,45 105,16 -9,77% 7,46% 3.070.700
12/09/2022 117,43 117,98 114,61 116,55 -1,60% 2,87% 766.300
09/09/2022 118,27 120,23 117,49 118,44 -0,67% 2,32% 770.000
08/09/2022 113,63 119,33 113,10 119,24 +5,62% 5,48% 1.383.400
07/09/2022 108,57 113,91 107,98 112,90 +3,88% 5,46% 835.800
06/09/2022 108,96 109,56 106,34 108,68 -0,64% 2,96% 620.000
02/09/2022 110,99 113,30 109,17 109,38 -0,64% 3,72% 644.500
01/09/2022 108,93 110,24 106,67 110,08 +0,64% 3,28% 662.800
31/08/2022 109,18 110,83 108,95 109,38 +0,06% 1,72% 601.700
30/08/2022 110,54 110,76 107,46 109,31 -0,88% 2,99% 492.800
29/08/2022 111,01 111,94 109,52 110,28 -1,44% 2,18% 606.500